Travere announces proposed convertible senior notes offering

San diego, march 08, 2022 (globe newswire) -- travere therapeutics, inc. (nasdaq: tvtx) today announced its intention to offer, subject to market and other conditions, $250 million aggregate principal amount of convertible senior notes due 2029 (the “notes”) in an underwritten offering. travere also expects to grant the underwriters of the notes an option to purchase, for settlement on or before march 31, 2022, up to an additional $37.5 million aggregate principal amount of notes, solely to cover over-allotments. as described in more detail below, travere intends to use a portion of the net proceeds from the offering to repurchase a portion of its currently outstanding convertible notes.
TVTX Ratings Summary
TVTX Quant Ranking